Publication:
Correction to: Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel (European Journal of Clinical Pharmacology, (2018), 74, 4, (443-451), 10.1007/s00228-017-2401-5)

dc.contributor.authorNovkovic, Mirjana (57191976429)
dc.contributor.authorMatic, Dragan (25959220100)
dc.contributor.authorKusic-Tisma, Jelena (6506936932)
dc.contributor.authorAntonijevic, Nebojsa (6602303948)
dc.contributor.authorRadojkovic, Dragica (6602844151)
dc.contributor.authorRakicevic, Ljiljana (14047140100)
dc.date.accessioned2025-06-12T16:30:46Z
dc.date.available2025-06-12T16:30:46Z
dc.date.issued2018
dc.description.abstractThe correct Author names are shown in this paper. The original article was corrected. © 2018, Springer-Verlag GmbH Germany, part of Springer Nature.
dc.identifier.urihttps://doi.org/10.1007/s00228-018-2425-5
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85044190548&doi=10.1007%2fs00228-018-2425-5&partnerID=40&md5=9ec1c7de9178a310072bef25bf542b45
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/6406
dc.titleCorrection to: Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel (European Journal of Clinical Pharmacology, (2018), 74, 4, (443-451), 10.1007/s00228-017-2401-5)
dspace.entity.typePublication

Files